SystImmune Tech Stack

Immuno-oncology biotech developing multi-specific antibodies and ADCs

Biotechnology Research Redmond, Washington 51–200 employees Founded 2014 Privately Held

SystImmune is a Redmond-based immuno-oncology company building bi-specific and tri-specific antibodies plus antibody-drug conjugates (ADCs) to target solid tumors. The tech stack reveals a clinical-development-focused operation: heavy reliance on SAS, Spotfire, and Medidata Rave for trial management and data analysis, plus emerging AI tooling (LLaMA, LangChain, ProteinMPNN) suggesting computational protein design is entering their workflow. Hiring velocity is accelerating with research roles leading (19 open), alongside a growing data team (5 roles), pointing toward scale-up of both lab throughput and computational analysis.

Tech Stack 40 technologies

Core StackSAS Python Palo Alto Networks Cisco VMware Hyper-V LangChain MariaDB Spotfire Concur GraphPad Prism Leica CDISC LIMS IronPython Datto RMM TeamViewer GoToAssist Logitech Ubuntu CentOS Debian Azure Medidata Rave Veeva EDC ProteinMPNN LLaMA Milvus Dask Ray+9 more

What SystImmune Is Building

◆Challenges

Patient recruitment barriers
Tmf inspection readiness
Reducing site activation timelines
Identifying partnership opportunities
Vendor oversight
Tmf health monitoring
Managing safety data from multiple sources
On-time delivery of regulatory submissions
Complex clinical development programs
Timely processing of vendor invoices

▲Active Projects

Study plan development
Ihc assay development and validation
Cdx ihc kit development
Study start-up activities for assigned clinical trials
Medidata rave study design
Continuous improvement initiatives related to start-up processes and tools
Ctms integration with tmf
Global tmf sop development
Tmf health check program
Generation of aggregate safety reports

Hiring Activity

Accelerating40 roles · 30 in 30d

Department

Research

Data

Healthcare

Ops

Finance

Sales

Engineering

Seniority

Senior

Mid

Director

Intern

Junior

Principal

Manager

Notable leadership hires: Head of Quality

Company intelligence

Find more companies like SystImmune by tech stack, pain points and active projects

Get started free

About SystImmune

SystImmune develops biologics that intervene in the solid tumor microenvironment through direct tumor attack or immune-system activation. Founded in 2014, the company operates a 51–200 person team across research, clinical operations, data, and quality functions. The project list—study plan development, IHC assay validation, Medidata Rave implementations, TMF (trial master file) health checks, and regulatory submissions—reflects a mid-stage biotech actively running clinical programs while building process infrastructure. Pain points center on trial execution velocity (site activation timelines, patient recruitment, vendor management) and regulatory readiness (TMF inspection preparation, safety data consolidation).

HeadquartersRedmond, Washington

Company Size51–200 employees

Founded2014

Hiring MarketsUnited States, China

Frequently Asked Questions

What is SystImmune's technology platform?

SystImmune develops bi-specific and tri-specific antibodies and antibody-drug conjugates (ADCs) targeting solid tumors through microenvironment intervention.

Where is SystImmune located?

Headquarters in Redmond, Washington. The company also actively hires in China alongside U.S. roles.

How this profile is built

SystImmune's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.